Cite
APA Citation
Graveno, M. E., Carulli, A., Freyer, C. W., Mangan, B. L., Nietupski, R., Loren, A. W., Frey, N. V., Porter, D. L., Gill, S. I., Hexner, E. O., Luger, S. M., Martin, M. E., McCurdy, S. R., Perl, A. E., Babushok, D. V., & Pratz, K. W. (2022). venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia. Leukemia & lymphoma, 63(7), 1645–1650. http://access.bl.uk/ark:/81055/vdc_100159165107.0x000034